All data are based on the daily closing price as of September 1, 2025
h
Humedix
200670.KQ
38.07 USD
-0.96
-2.46%
Overview
Last close
38.07 usd
Market cap
392.84M usd
52 week high
54.97 usd
52 week low
18.18 usd
Target price
40.58 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
5.0488
Price/Book Value
2.2579
Enterprise Value
314.38M usd
EV/Revenue
2.7712
EV/EBITDA
6.7133
Key financials
Revenue TTM
79.72M usd
Gross Profit TTM
31.65M usd
EBITDA TTM
20.30M usd
Earnings per Share
N/A usd
Dividend
0.34 usd
Total assets
198.58M usd
Net debt
N/A usd
About
Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.